Sunil Healthcare Ltd (SUNLOC) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sunil Healthcare Ltd on NSE and BSE, with an AI summary of each filing.
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Intimation · 13 Nov 2026, 5:30 am
Sunil Healthcare Board Meeting on 13th Nov'26 to Consider Q2 Results Sunil Healthcare Ltd. has scheduled its 271st Board of Directors meeting for 13th Nov'26 via video conferencing. The board will consider, approve, and take on record the unaudited standalone and consolidated financial results for the second quarter and first half-year ended 30th Sep'26 (FY27). Additionally, the trading window for designated persons remains closed from 1st Oct'26 until 15th Nov'26 (both days inclusive) pursuant to SEBI insider trading regulations.
Revision of Credit Ratings
Others (Uncategorized) · 05 Oct 2026, 7:49 pm
Sunil Healthcare Credit Ratings Upgraded by Brickwork Ratings Brickwork Ratings upgraded Sunil Healthcare Limited's credit ratings for bank facilities, effective 3rd Oct'26. The company's long-term bank facilities rating was upgraded to BWRBBB- with a Stable outlook, up from CARE BB+ (Outlook Stable) previously assigned by Care Ratings Limited. Additionally, its short-term bank facilities rating was upgraded to BWR A3 from CARE A4+.
Voting Results and Scrutinizers Report dated 29.09.2026 of 52nd AGM of Sunil Healthcare Limited held on Monday, 28th September 2026 at 12.30 P.M.
Annual General Meeting · 29 Sept 2026, 10:18 pm
Proceedings of 52nd AGM of Sunil Healthcare Limited held on Monday, 28th September 2026 at 12.30 P.M.
Annual General Meeting · 28 Sept 2026, 8:23 pm
Annual Report for the FY 2025-26
Others (Uncategorized) · 02 Sept 2026, 9:46 pm
Notice of 52nd Annual General Meeting of the Company,. Remote-E-voting/E-voting and other information
Annual General Meeting · 02 Sept 2026, 9:33 pm
Outcome of Board meeting held on 13th August 2026
Outcome · 14 Aug 2026, 12:29 am
Sunil Healthcare Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 1,899 (-16.1% YoY | -3.7% QoQ) ■ EBITDA: 293 (-10.7% YoY | +50.9% QoQ) ■ EBITDA Margin (%): 15.4 (+94 bps YoY | +558 bps QoQ) ■ PAT: 46.3 (-49.0% YoY | -69.5% QoQ) ■ EPS (INR): 0.45 (-49.4% YoY | -69.6% QoQ)
approved un-audited financial results (both standalone and consolidated) for the 1st quarter of FY 2026-27 ended on 30.06.2026
Financial Result · 14 Aug 2026, 12:26 am
Sunil Healthcare Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 1,899 (-16.1% YoY | -3.7% QoQ) ■ EBITDA: 293 (-10.7% YoY | +50.9% QoQ) ■ EBITDA Margin (%): 15.4 (+94 bps YoY | +558 bps QoQ) ■ PAT: 46.3 (-49.0% YoY | -69.5% QoQ) ■ EPS (INR): 0.45 (-49.4% YoY | -69.6% QoQ)
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Board Meeting scheduled to ....
Intimation · 13 Aug 2026, 5:30 am
Sunil Healthcare Board Meeting on Aug 13, 2026, for Q1 FY27 Results Sunil Healthcare (BSE: 537253) has scheduled a Board of Directors meeting on 13 Aug'26 to consider and approve the un-audited standalone and consolidated financial results for the first quarter ended 30 Jun'26. In accordance with insider trading regulations, the trading window for designated persons will remain closed from 01 Jul'26 to 15 Aug'26, inclusive.
Special window for Transfer and Dematerialisation of Physical Securities
Others (Uncategorized) · 30 Jun 2026, 9:30 pm
Sunil Healthcare Opens One-Year Window for Demat of Physical Shares Sunil Healthcare Ltd. announced a special window for transferring and dematerializing physical securities, active from 5th Feb'26 to 4th Feb'27. This applies to investors who purchased shares before 1st Apr'19 but failed to lodge them for transfer or had their requests rejected. Eligibility requires the original security certificate and a transfer deed dated before 1st Apr'19. Transferred securities will be credited only in demat form and subject to a one-year lock-in period, during which they cannot be transferred, lien-marked, or pledged.
Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended 31.03.2026
Financial Result · 30 May 2026, 3:56 am
Sunil Healthcare Q4'26 Results Hit by Exceptional Items; No Dividend Declared Sunil Healthcare reported a consolidated Q4'26 net loss of ₹141.66 Lakhs versus a ₹20.51 Lakhs profit YoY, driven by exceptional items totaling ₹958.25 Lakhs. Revenue from operations for the quarter stood at ₹1,972.23 Lakhs, down 7.0% YoY. For the full year FY26, consolidated net profit was ₹400.60 Lakhs against ₹20.51 Lakhs in FY25. The Board has not recommended a dividend for FY26. M/s. Agrawal S. Lal & Co. were appointed as new Internal Auditors for FY27.
Outcome of the 269th Board Meeting of the Company held on 29.05.2026
Outcome · 30 May 2026, 3:51 am
Sunil Healthcare Board Approves FY26 Results, Skips Dividend Sunil Healthcare's board approved audited financial results for Q4 and FY ended 31 Mar'26. For FY26, consolidated profit after tax was ₹400.60 lakhs versus a loss of ₹141.66 lakhs YoY. Consolidated revenue from operations was ₹8,771.92 lakhs, up from ₹8,342.11 lakhs YoY. The board did not recommend a dividend for FY25-26. The auditor's report contained an unmodified opinion. M/s. Agrawal S. Lal & Co. were appointed as internal auditors for FY26-27. The company recognized exceptional items in the quarter.
Approved Audited Financial Results (Standalone and Consolidated) for the quarter/year ended March 31, 2026
Financial Result · 30 May 2026, 3:42 am
Sunil Healthcare Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 1,972 (-7.0% YoY | -9.7% QoQ) ■ EBITDA: 194 (-36.0% YoY | -46.4% QoQ) ■ EBITDA Margin (%): 9.8 (-446 bps YoY | -675 bps QoQ) ■ PAT: 152 (+317.1% YoY | +159.1% QoQ) ■ EPS (INR): 1.48 (+322.9% YoY | +159.6% QoQ)
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Meeting of the Board of Directors ....
Intimation · 29 May 2026, 5:30 am
Sunil Healthcare Board Meeting Scheduled for Q4 & FY26 Results Sunil Healthcare Ltd. will hold a Board of Directors meeting on 29th May'26 to consider and approve the audited standalone and consolidated financial results for the fourth quarter and full financial year ended 31st Mar'26. The trading window for insiders will remain closed from 01st Apr'26 until 31st May'26, inclusive. The meeting will be conducted via video conferencing.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 24 Apr 2026, 9:16 pm
Sunil Healthcare Clarifies Status as Not a Large Corporate Sunil Healthcare Limited (BSE: 537253) confirmed on 24 Apr'26 that it does not qualify as a Large Corporate (LC) under SEBI's framework. This exempts it from mandatory fundraising requirements through debt securities. The company reported outstanding borrowings of ₹19.08 crore as of 31 Mar'26. During FY26, its highest credit rating was CARE BB+ with a Stable outlook from CARE Ratings Ltd. The disclosure clarifies the company's regulatory obligations regarding debt issuance.
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are pleased to inform, that the Board of Directors of the Company at their Board Meeting held on Friday, February 06, ....
Outcome · 06 Feb 2026, 11:40 pm
Sunil Healthcare Board Approves Q3 FY26 Unaudited Financial Results Sunil Healthcare's board approved unaudited results for the quarter ending 31 Dec'25. Consolidated profit after tax was ₹58.52 lakhs, down from ₹99.69 lakhs QoQ but recovering from a loss of ₹54.05 lakhs YoY. Revenue from operations stood at ₹2,183.73 lakhs, a decrease from ₹2,351.76 lakhs QoQ but an increase from ₹2,046.43 lakhs YoY. The consolidated EPS for the quarter was ₹0.57. Total expenses remained relatively flat QoQ at ₹2,149.26 lakhs. The results were approved on 06 Feb'26.
Board at its meeting held today interalia approved Unaudited Financial Results (both standalone and consolidated) for the quarter and nine months ended 31.12.2025 of FY 2025-26
Financial Result · 06 Feb 2026, 11:33 pm
SUNIL HEALTHCARE LIMITED - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lakhs) ■ Revenue: 2184 (+6.7% YoY | -7.1% QoQ) ■ EBITDA: 362 (+34.0% YoY | -7.6% QoQ) ■ EBITDA Margin (%): 16.6 (+338 bps YoY | -9 bps QoQ) ■ PAT: 58.5 (Loss to Profit YoY | -41.3% QoQ) ■ EPS (INR): 0.57 (Loss to Profit YoY | -41.2% QoQ)
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Intimation · 06 Feb 2026, 5:30 am
Sunil Healthcare Board to Approve Q3 FY26 Results on Feb 06 Sunil Healthcare's Board of Directors will meet on 06 Feb'26 to consider and approve the un-audited standalone and consolidated financial results for the third quarter and nine months ending 31 Dec'25. The results will be subject to a Limited Review by the statutory auditors. In connection with this, the trading window for insiders will remain closed from 01 Jan'26 through 08 Feb'26, inclusive.
Board of Directors at its meeting held today on 04.11.2025 interalia approved un-audited financial results(both standalone and consolidated) for the quarter/half year ended 30.09.2025
Outcome · 05 Nov 2025, 12:14 am
Board of Directors at its meeting held today on 04.11.2025 interalia approved Unaudited Financial results (both standalone and consolidated) for the quarter/half year ended 30.09.2025
Financial Result · 05 Nov 2025, 12:10 am
Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 ,inter alia, to consider and approve Board Meeting of the Company ....
Intimation · 04 Nov 2025, 5:30 am
Approval of appointment of M/s. ATCS & Associates, Company Secretaries as Secretarial Auditors of the Company for a term of 5 consecutive years from the FY 2025-26 upto FY 2029-30 by the ....
Annual General Meeting · 30 Sept 2025, 10:07 pm
Declaration of results alongwith scrutinizers'' report of the 51st annual General Meeting of the Company held on September 29, 2025 pursuant to Regulation 44(3) of SEBI (LODR) regulations 2015
Annual General Meeting · 30 Sept 2025, 9:27 pm
Proceedings of 51st Annual General Meeting of the Company held on 29th September 2025 pursuant to Regulation 30 of SEBI (LODR) Regulations
Annual General Meeting · 29 Sept 2025, 9:31 pm
ANNUAL REPORT FOR THE FINANCIAL YEAR 2024-25
Others (Uncategorized) · 03 Sept 2025, 11:52 pm